A new study warns that GLP-1 weight-loss drugs like Ozempic and Wegovy may cause false cancer signals on PET-CT scans, ...

Popular weight-loss drugs Ozempic and others can affect medical scans. New research shows these medications interfere with ...

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...

A new study reveals that GLP-1 drugs may affect medical scan results, though experts say findings are preliminary and more ...

The rise of GLP-1s prescribed for weight loss and type 2 diabetes is leading to potentially misleading patterns in cancer scans.

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

New research suggests weight loss jabs like GLP-1s could affect cancer scans. These drugs might make scans appear abnormal, ...

GLP-1 receptor agonists have long half-lives so a patient would need to stop taking it a month before a scan for it to completely eliminate the risk of it influencing the imaging. Gadaleta noted that ...

Experts warn the strange side effect could lead to delayed diagnoses and treatments, as well as unnecessary medical ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society ...

A new “unusual” side effect of weight-loss drugs is becoming more common, research has suggested. Weight-loss drugs such as ...